Abstract
9533Background: coBRIM (Larkin J et al. N Engl J Med 2014;371:1867-1876.) showed significant improvement in PFS and OS with C+V treatment for advanced BRAF-mutated melanoma patients (pts) but was a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
